相关实验视频
Updated: Aug 14, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
特定的血小板媒介和不稳定的冠状动脉病变. 实验证据和潜在的临床影响
J T Willerson1, P Golino, J Eidt
1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-9047.
Circulation
|July 1, 1989
概括
不稳定的心痛和心肌梗塞源于血小板聚合和血管收缩,这是由于血栓和血清素. 这些因素造成的长期冠状动脉阻塞会导致心肌损伤.
科学领域:
- 心脏病学 心脏病学
- 血管生物学 血管生物学
- 病理生理学 病理生理学
背景情况:
- 慢性稳定性胸痛可以发展为不稳定性胸痛和急性心肌梗塞.
- 假设这种进展涉及由血小板聚合和血管收缩驱动的心肌缺血.
- 血管活性物质的局部不平衡和内皮功能障碍与此有关.
研究的目的:
- 探索不稳定性 angina 和急性心肌梗塞之间的病理生理连续性.
- 调查血小板聚合和冠状动脉血管收缩在缺血性心脏事件中的作用.
- 为了阐明血栓,血和内皮衍生因素的贡献.
主要方法:
- 现有假设和证据的投机性审查.
- 分析导致冠状动脉狭窄和内皮损伤的机制.
- 缺血事件持续时间与临床结果的相关性.
主要成果:
- 血小板聚合和血管收缩,由血栓和血清介导,导致心肌缺血.
- 降低EDRF和前环素等血管扩张剂的水平会加剧这些影响.
- 冠状动脉阻塞的持续时间决定了严重程度,从不稳定的心痛到Q波心肌梗塞.
结论:
- 不稳定的心痛和急性心肌梗塞代表了冠状动脉血栓形成和血管收缩的谱.
- 短暂的发作会导致不稳定的心痛或非Q波性心脏病发作.
- 长期阻塞导致Q波心肌梗塞,与慢性内皮损伤和狭窄相关.
相关概念视频
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...